Feijen and colleagues sought to ascertain the optimal doxorubicin dose-equivalence ratios for late-onset cardiomyopathy between doxorubicin and other anthracyclines or mitoxantrone. The ...

Subclinical cardiomyopathy was defined by decrease of left ventricular fractional shortening (FS) without clinical signs of CHF. Cumulative dose of doxorubicin, male sex, older age, relapse, ...

Transient cardiomyopathy developed 16 months after the completion of doxorubicin therapy in one patient treated with doxorubicin alone. Figure 1 shows the Kaplan–Meier estimates of event-free ...

but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation. In this issue of the Journal of ...

A lawsuit was filed against Dr T. In the lawsuit, Mrs B claimed that the doxorubicin-induced cardiotoxicity had caused her to suffer permanent cardiomyopathy, severe mitral valve regurgitation ...

Doxorubicin HCl 10mg/vial, 20mg/vial, 50mg/vial; pwd for IV inj after reconstitution; contains lactose. Risk of cardiomyopathy (including left ventricular failure), arrhythmias. Pre-existing heart ...

1 Cardiotoxicity associated with the administration of doxorubicin is most commonly manifested by dose-dependent chronic cardiomyopathy, and acute effects, including left ventricular failure ...

but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation. In this issue of the Journal of ...